Next Article in Journal
Nanomedicine Faces Barriers
Previous Article in Journal
Anti-Viral Drugs for Human Adenoviruses
Previous Article in Special Issue
Cannabinoids and Reproduction: A Lasting and Intriguing History
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(11), 3355-3370;

Inactivation of Anandamide Signaling: A Continuing Debate

School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, Scotland, UK
Author to whom correspondence should be addressed.
Received: 25 August 2010 / Revised: 9 October 2010 / Accepted: 25 October 2010 / Published: 28 October 2010
(This article belongs to the Special Issue Cannabinoids)
Full-Text   |   PDF [186 KB, uploaded 28 October 2010]   |  


Since the first endocannabinoid anandamide was identified in 1992, extensive research has been conducted to characterize the elements of the tightly controlled endocannabinoid signaling system. While it was established that the activity of endocannabinoids are terminated by a two-step process that includes cellular uptake and degradation, there is still a continuing debate about the mechanistic role of these processes in inactivating anandamide signals. View Full-Text
Keywords: endocannabinoid inactivation; anandamide; ethanolamine endocannabinoid inactivation; anandamide; ethanolamine

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Khairy, H.; Houssen, W.E. Inactivation of Anandamide Signaling: A Continuing Debate. Pharmaceuticals 2010, 3, 3355-3370.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top